Page No 1 2 |
Phrase | Consultant | Town | Special Interests |
Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, prostate cancer, radiotherapy, bladder cancer |
Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, bladder cancer, gastrointestinal cancer, upper gastrointestinal disease, colorectal / bowel cancer, prostate cancer |
Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, bladder cancer, lung cancer |
Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, head and neck cancer, thyroid cancer, genito-urinary, skin cancer |
Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, colorectal cancer, oesophagogastric cancer |
Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer, upper gastrointestinal cancers, GIST - gastrointestinal stromal tumours, pancreatic cancer, biliary cancer, melanomas, lymphomas |
Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, head and neck cancer |
Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, lung cancer, immunotherapy, radiotherapy, biological therapy, chemotherapy |
Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, skin cancer, renal tumours, skin lymphoma |
Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, colorectal cancer, breast cancer, ovarian cancer, urological cancer |
Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, upper and lower gastrointestinal cancer, breast cancer, radiotherapy |
Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, colorectal cancer, prostate cancer, gastrointestinal cancer |
Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, kidney cancer, urological oncology, head and neck cancer |
Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer, bowel cancer |
Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, colorectal cancer, anal cancer |
Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, head and neck cancer |
Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer, colorectal cancer |
clinical oncology | *Consultant(s)* | *Towns* | Medical oncology, clinical oncology, upper and lower gastrointestinal malignancies, urological cancers, oesophageal cancer |
Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, colorectal cancer, lymphoma |
Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, cancer research, melanoma, skin cancers, immunotherapy |
Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, urological cancer, lung cancer |
Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, upper gastrointestinal cancer, colorectal cancer, gynaecological malignancies, head and neck cancers |
Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, skin cancer, bladder cancer, prostate cancer |
Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, head and neck cancer, general oncology, radiotherapy and cyberknife |
Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, intrathoracic cancers including lung mesothelioma, upper gastrointestinal and hepatobiliary cancers, skin cancer - melanomas, breast cancer, immunotherapy |
Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, colorectal cancer, ovarian cancer |
Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, gynaecological oncology, brachytherapy, colorectal cancer |
Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, bowel cancer, urological oncology, breast cancer, patient information, consent |
Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, oncology: breast, prostate, renal, bladder, chemotherapy, radiotherapy |
Clinical Pharmacology | *Consultant(s)* | *Towns* | Hypertension, cardiovascular medicine |
Clinical radiology | *Consultant(s)* | *Towns* | Clinical radiology, diagnostic imaging, MRI, CT scanning, neonatal hip ultrasound, vascular imaging |
Clinical radiology | *Consultant(s)* | *Towns* | Clinical radiology, interventional radiology, vascular and non-vascular radiology |
clinical research lead | *Consultant(s)* | *Towns* | Interventional cardiology, clinical research lead, general adult cardiology |
clinical risk management | *Consultant(s)* | *Towns* | Prolapse surgery, ovarian cysts, pelvic pain/endometriosis, menstrual irregularities, hysteroscopy, fibroids, twins, post delivery pelvic floor injuries, perineal refashioning, clinical risk management, minimally invasive/laparoscopic surgery, female post reproductive health/menopause |
Clinical Standard panel member - British Cardiac Society | *Consultant(s)* | *Towns* | Acute and general internal medicine, stroke medicine, TIA - transient ischaemic attack, arrhythmia, cardiac CT, nuclear reporting, heart failure, falls and syncope, echocardiography, coronary artery disease, lipids, Oxford Regional Specialty Advisor for Cardiology, Clinical Standard panel member - British Cardiac Society |
clinical trials | *Consultant(s)* | *Towns* | Headache, MS - multiple sclerosis, Parkinson's disease, stroke, general neurology, clinical trials, dementia |
clinical trials | *Consultant(s)* | *Towns* | Medical oncology, hepatobiliary cancer, pancreatic cancer, melanoma, clinical trials |
Honorary Senior Clinical Lecturer at Queen Mary University of London | *Consultant(s)* | *Towns* | Stone surgery, stone prevention and metabolic testing, HOLEP - holmium laser enucleation of the prostate and laser prostatectomy, general urology including penoscrotal work, lasering of bladder TCC - transitional cell carcinoma under local anaesthetic, complex endourology, education - Director of Medical Education, Honorary Senior Clinical Lecturer at Queen Mary University of London |
research and clinical trials | *Consultant(s)* | *Towns* | Acute coronary syndromes, heart failure, arrhythmia, hypertension, metabolic syndrome, health economics, research and clinical trials, medical statistics, cardiology guidelines, cardiovascular epidemiology, valve disease, device therapy, audit and national policy, atypical chest pain, cardiac risk reduction |
Page No 1 2 |
|